While Big Pharma chases blockbuster drugs, ConnectMed360 operates in the shadows where access meets desperation. They don't manufacture therapies—they manufacture access to cancer, rare, and complex treatments that patients can't get anywhere else.

"They're not competing for traffic—they're competing for trust in an industry where a failed connection means a patient doesn't get their medication."

Their tech stack—jQuery, Tailwind, Bootstrap—tells the story of a company that built just enough digital infrastructure to support human operations, not replace them. No fancy SPA frameworks, no aggressive SEO content farms. They're optimized for operational efficiency, not viral growth.

• Bridges the gap between manufacturer and patient access programs
• Specializes in cancer, rare, and complex therapies where standard channels fail
• Operates as a high-touch concierge, not a self-service platform
• Built on trust and relationships, not algorithmic matching